Drug Profile
BGC 200761
Alternative Names: BGC-20-761; BGC20-0761Latest Information Update: 21 Aug 2019
Price :
$50
*
At a glance
- Originator BTG
- Class Antipsychotics; Nootropics
- Mechanism of Action Serotonin 2A receptor antagonists; Serotonin 6 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 19 Aug 2019 BTG has been acquired by Boston Scientific Corporation
- 04 Nov 2017 No recent reports of development identified for preclinical development in Schizophrenia in USA (PO)
- 08 Apr 2008 Preclinical development is ongoing